Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CCR2 | P41597 | 5/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.34 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | TLR4 | O00206 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9766490 | 0.93 | CYP1A2 (0.49) | CYP1A2CCR2HTTALDH1A1L3MBTL1 | |
| SCHEMBL26718370 | 0.89 | CYP1A2 (0.46) | CYP1A2CCR2NAAATDP1HTT | |
| SCHEMBL2482364 | 0.89 | CHRNA7 (0.38) | CYP1A2CCR2HTTALDH1A1OR51E2 | |
| SCHEMBL1567651 | 0.84 | CYP1A2 (0.53) | CYP1A2CCR2NAAAALDH1A1L3MBTL1 | |
| SCHEMBL27924745 | 0.83 | OR51E2 (0.33) | CYP1A2OR51E2FKBP5CRBN | |
| SCHEMBL28731850 | 0.83 | SIGMAR1 (0.40) | CYP1A2TDP1OR51E2FKBP5CRBN | |
| SCHEMBL7626924 | 0.83 | CYP1A2 (0.51) | CYP1A2CCR2NAAAALDH1A1L3MBTL1 | |
| SCHEMBL7624660 | 0.83 | CYP1A2 (0.51) | CYP1A2CCR2NAAAALDH1A1L3MBTL1 | |
| SCHEMBL2526110 | 0.82 | HTT (0.41) | CCR2HTTALDH1A1OR51E2L3MBTL1 | |
| SCHEMBL5014640 | 0.80 | OR51E2 (0.37) | OR51E2FKBP5CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080182773-A1 | Thickeners Based on Polymers Comprising Amine Groups | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-31 | — | — | US | claimed |
| EP-1863574-A1 | THICKENER BASED ON AMINE GROUP-CONTAINING POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-12 | — | — | EP | claimed |
| WO-2006100299-A1 | THICKENER BASED ON AMINE GROUP-CONTAINING POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-28 | — | — | WO | claimed |
| CN-120157874-A | High-elasticity light nylon elastomer and hydrolytic polymerization preparation method thereof | 浙江恒逸石化研究院有限公司 | 2025-06-17 | — | — | CN | disclosed |
| EP-2170964-B1 | HIGH-CATION COPOLYMERS BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2017-02-22 | — | — | EP | disclosed |
| WO-2017012963-A1 | POLYMERIZABLE FATTY ACID-DERIVATIVE-MONOMERS WITH TERMINAL OLEFINIC DOUBLE BONDS, POLYMERS CONTAINING SAME MONOMERS, PRODUCTION AND USE THEREOF | BASF SE (DE) | 2017-01-26 | — | — | WO | disclosed |
| US-8623343-B2 | Highly cationic copolymers based on quaternized nitrogen-containing monomers | BASF SE (DE) | 2014-01-07 | — | — | US | disclosed |
| US-20130108959-A1 | USE OF A COMPOSITION COMPRISING VINYL MONOMER-COMPRISING POLYMER, SOLVENT AND AT LEAST ONE HALOGEN-FREE BIOCIDE | BASF SE (DE) | 2013-05-02 | — | — | US | disclosed |
| US-20120118446-A1 | AQUEOUS METAL QUENCHING MEDIUM | BASF SE (DE) | 2012-05-17 | — | — | US | disclosed |
| EP-2376550-A1 | MODIFIED POLYVINYLLACTAMS | BASF SE (DE) | 2011-10-19 | — | — | EP | disclosed |
| US-20110248428-A1 | MODIFIED POLYVINYLLACTAMS | BASF SE (DE) | 2011-10-13 | — | — | US | disclosed |
| WO-2006100299-A1 | THICKENER BASED ON AMINE GROUP-CONTAINING POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-28 | — | — | WO | disclosed |
| EP-1240139-B1 | METHOD FOR PRODUCING N-ALKENYL AMIDES | BASF AG (DE) | 2005-11-09 | — | — | EP | disclosed |
| US-6794546-B2 | REACTION OF CORRESPONDING OH, SH OR NH COMPOUND WITH AN ACETYLENE IN LIQUID PHASE IN PRESENCE OF BASIC ALKALI OR ALKALINE EARTH METAL COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-21 | — | — | US | disclosed |
| EP-1240140-B1 | METHOD FOR THE PRODUCTION OF N-ALKENYL AMIDES | BASF AG (DE) | 2004-03-17 | — | — | EP | disclosed |
| US-6673920-B2 | REACTING AMIDES WITH ACETYLENES IN THE LIQUID PHASE IN THE PRESENCE OF BASIC ALKALI METAL COMPOUNDS AND OF A COCATALYST, WHICH COMPRISES USING AS THE COCATALYST DIOLS TO PREPARE N-ALKENYL-AMIDE | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-06 | — | — | US | disclosed |
| US-6624303-B2 | By reacting the corresponding NH-amides with acetylenes in the liquid phase using a basic alkali metal compound as catalyst and as cocatalyst (di- or tri-)1,4-butanediol mono- and diethers; N-vinyl-2-pyrrolidone from pyrrolidone | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-23 | — | — | US | disclosed |
| US-20030105354-A1 | Reaction of corresponding OH, SH or NH compound with an acetylene in liquid phase in presence of basic alkali or alkaline earth metal compounds | BASF AKTIENGESELLSCHAFT (DE) | 2003-06-05 | — | — | US | disclosed |
| US-20030036659-A1 | Method for the production of n-alkenyl amides | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-20 | — | — | US | disclosed |
| US-20030028035-A1 | Method for producing n-alkenyl amides | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030036659-A1 | Method for the production of n-alkenyl amides | NAT1, SAT1, AGPAT2 | CYP1A2 184/4885CCR2 1245/4885NAAA 7/4885 |
| US-20030028035-A1 | Method for producing n-alkenyl amides | NAT1, H1-2, H1-0 | CYP1A2 435/4885CCR2 377/4885NAAA 48/4885 |
| US-20030105354-A1 | Reaction of corresponding OH, SH or NH compound with an acetylene in liquid phase in presence of basic alkali or alkaline earth metal compounds | H1-0, HAT1, H1-3 | CYP1A2 1740/4885CCR2 4858/4885NAAA 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.